Concepedia

Author

Patrizia Nanni

University of BolognaORCID

Also Known As

C De Giovanni, Nanni, Patrizia, P NANNI, P Nanni, P. G. Nanni, P. NANNI, P. Nanni, PATRIZIA NANNI, Patrizia Nanni

278

Publications

8K

Citations

51

H-Index

103

Concepts

All Affiliations

University of BolognaIstituto Ortopedico RizzoliUniversity of Chieti-PescaraUniversity of TurinFondazione IRCCS Istituto Nazionale dei Tumori
PN

About

Patrizia Nanni is an author at University of Bologna specializing in medicine, tumor biology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

33

63

3.2K

2

Cell Biology

26

48

2.4K

3

Health Sciences

8

8

317

4

Allergy

4

4

353

5

Engineering

1

1

99

Patrizia Nanni

×

114

Publications

6.9K

Citations

49

H-Index

YearCitations

2011: the immune hallmarks of cancer

Federica Cavallo, Carla De Giovanni, Patrizia Nanni,

Cancer Immunology Immunotherapy

2011

414

DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice  

Stefania Rovero, Augusto Amici, Emma Di Carlo,

The Journal of Immunology

2000

356

Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/<i>neu</i> Transgenic Mice

K Boggio, Giordano Nicoletti, Emma Di Carlo,

The Journal of Experimental Medicine

1998

300

Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice

Patrizia Nanni, Giordano Nicoletti, Carla De Giovanni,

The Journal of Experimental Medicine

2001

232

TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma

Patrizia Nanni, Carla De Giovanni, Pier‐Luigi Lollini,

Clinical & Experimental Metastasis

1983

224

Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice.

Katia Scotlandi, Stefania Benini, Patrizia Nanni,

PubMed

1998

189

Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.

Alessandra Allione, M Consalvo, Patrizia Nanni,

PubMed

1994

162

Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells.

Stefania Benini, Maria Cristina Manara, Nicola Baldini,

PubMed

2001

141

Preclinical <i>In vivo</i> Study of New Insulin-Like Growth Factor-I Receptor–Specific Inhibitor in Ewing's Sarcoma

Maria Cristina Manara, Lorena Landuzzi, Patrizia Nanni,

Clinical Cancer Research

2007

133

Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas.

Riccardo Ferracini, Martina Olivero, Maria Flavia Di Renzo,

PubMed

1996

124

Page 1